Goldschmidt H - Search Results

1

Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study.

Bochtler T, Hegenbart U, Kunz C, Benner A, Kimmich C, Seckinger A, Hose D, Goldschmidt H, Granzow M, Dreger P, Ho AD, Jauch A, Schönland SO. Bochtler T, et al. Among authors: goldschmidt h. Blood. 2016 Jul 28;128(4):594-602. doi: 10.1182/blood-2015-10-676361. Epub 2016 Jun 2. Blood. 2016. PMID: 27257181 Free article. Clinical Trial.

2

Harter C, Salwender HJ, Bach A, Egerer G, Goldschmidt H, Ho AD. Harter C, et al. Among authors: goldschmidt h. Cancer. 2002 Jan 1;94(1):245-51. doi: 10.1002/cncr.10199. Cancer. 2002. PMID: 11815983 Free article. Clinical Trial.

3

Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.

Neben K, Mytilineos J, Moehler TM, Preiss A, Kraemer A, Ho AD, Opelz G, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Blood. 2002 Sep 15;100(6):2263-5. Blood. 2002. PMID: 12200397 Free article. Clinical Trial.

4

Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.

Neben K, Moehler T, Benner A, Kraemer A, Egerer G, Ho AD, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Clin Cancer Res. 2002 Nov;8(11):3377-82. Clin Cancer Res. 2002. PMID: 12429624 Clinical Trial.

5

Autologous bone marrow transplantation in adult patients with acute lymphoblastic leukemia.

Egerer G, Goldschmidt H, Zoz M, Ho AD. Egerer G, et al. Among authors: goldschmidt h. Leuk Lymphoma. 2003 Jan;44(1):9-14. doi: 10.1080/1042819021000040242. Leuk Lymphoma. 2003. PMID: 12691137 Review.

6

Kinetics of peripheral blood stem cell mobilization following G-CSF-supported chemotherapy.

Seggewiss R, Buss EC, Herrmann D, Goldschmidt H, Ho AD, Fruehauf S. Seggewiss R, et al. Among authors: goldschmidt h. Stem Cells. 2003;21(5):568-74. doi: 10.1634/stemcells.21-5-568. Stem Cells. 2003. PMID: 12968111

7

No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.

Zeier M, Perz J, Linke RP, Donini U, Waldherr R, Andrassy K, Ho AD, Goldschmidt H. Zeier M, et al. Among authors: goldschmidt h. Nephrol Dial Transplant. 2003 Dec;18(12):2644-7. doi: 10.1093/ndt/gfg436. Nephrol Dial Transplant. 2003. PMID: 14605290

8

Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.

Luft T, Moos M, Goldschmidt H, Ho AD, Görner M. Luft T, et al. Among authors: goldschmidt h. Br J Haematol. 2003 Nov;123(4):646-53. doi: 10.1046/j.1365-2141.2003.04670.x. Br J Haematol. 2003. PMID: 14616968 Free article.

9

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.

Witzens M, Moehler T, Neben K, Fruehauf S, Hartschuh W, Ho AD, Goldschmidt H. Witzens M, et al. Among authors: goldschmidt h. Ann Hematol. 2004 Jul;83(7):467-70. doi: 10.1007/s00277-003-0804-0. Epub 2003 Nov 19. Ann Hematol. 2004. PMID: 14625789

10

[Stem cells in hematology and oncology].

Goldschmidt H, Egerer G, Fruehauf S, Ho AD. Goldschmidt H, et al. Med Klin (Munich). 2003 Dec 15;98 Suppl 2:11-4. Med Klin (Munich). 2003. PMID: 14992195 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

845 results

Search Page

Filters